Showing results (1-10 of 1,646) with videos related to

Sort By:
Pageof 165
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 1, 1990
[Studies on the role of leukocytes in the activation of intravascular coagulation in septicemia]K Okajima, M Uchiba, H Okabe, et al.
American Journal of Hematology|March 1, 1997
Plasma levels of soluble E-selectin in patients with disseminated intravascular coagulationK Okajima, M Uchiba, K Murakami, et al.
Acta Haematologica|January 1, 1989
Characterization of the fibrinolytic state by measuring stable cross-linked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemiaK Okajima, S Koga, H Okabe, et al.
Thrombosis Research|November 1, 1995
Effects of antithrombin III (AT III) and Trp49-modified AT III on plasma level of 6-keto-PGF1 alpha in ratsM Uchiba, K Okajima, K Murakami, et al.
Thrombosis Research|April 15, 1995
Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in ratsM Uchiba, K Okajima, K Murakami, et al.
Thrombosis Research|April 15, 1994
Effect of nafamostat mesilate, a synthetic protease inhibitor, on tissue factor-factor VIIa complex activityM Uchiba, K Okajima, H Abe, et al.
Thrombosis and Haemostasis|February 19, 1990
Effect of protein C and activated protein C on coagulation and fibrinolysis in normal human subjectsK Okajima, S Koga, M Kaji, et al.
American Journal of Respiratory and Critical Care Medicine|February 1, 1997
Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in ratsM Uchiba, K Okajima, K Murakami, et al.
American Journal of Hematology|January 1, 1995
Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparinK Okajima, H Abe, M Wagatsuma, et al.
The American Journal of Physiology|June 1, 1996
Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin IIIM Uchiba, K Okajima, K Murakami, et al.
Pageof 165